Orlistat Tablets
Developed to target weight management, indicated to support dietary efforts to reduce body weight by inhibiting the digestion of dietary fats.
Strengths: 60 · 120mg
Where to Check Availability
Medicine details
- Conditions
- Alternative names
Xenical; Alli
- Therapeutic class
Anti-obesity Preparation
- Pharmacological class
Lipase Inhibitor
- Contraindications
chronic malabsorption syndrome; cholestasis; pregnancy
- Minor side effects
flatulence; faecal urgency; steatorrhoea
- Moderate side effects
abdominal pain; faecal incontinence
- Dosage forms
Tablet
- Administration route
Oral use
- Prescription status
POM
- Manufacturer
Roche
- Onset Time
1–2 days
- Duration
3–4 hours
- Storage instructions
Store below 25°C, away from moisture and direct heat.
- Drug interactions
warfarin; levothyroxine; ciclosporin
- Age restrictions
Recommended for adults only.
Precautions and warnings
maintain a low-fat diet; may reduce absorption of fat-soluble vitamins; use with a vitamin supplement
Serious side effects
liver injury — requires immediate medical attention; oxalate nephropathy — requires immediate medical attention
Patient summary
Developed to target weight management, indicated to support dietary efforts to reduce body weight by inhibiting the digestion of dietary fats.
Mechanism of action
Orlistat acts as a specific inhibitor of gastrointestinal lipases, reducing the absorption of a proportion of dietary fat consumed in a meal.
Pregnancy and breastfeeding
Pregnancy: Not recommended. Breastfeeding: Not recommended due to potential excretion in milk.
Orlistat Tablets
Developed to target weight management, indicated to support dietary efforts to reduce body weight by inhibiting the digestion of dietary fats.
Editorial Notes
- Active ingredient(s): Orlistat
- Listed indication(s): Obesity, Overweight
Usually available as
- 90 tablets - 60 mg562-60-mg-1630
- 90 tablets - 120 mg562-120-mg-1624